Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

A new study has found that an experimental drug appears to reduce the risk of Alzheimer’ s-related dementia in people ...

The newest cost savings estimates from DOGE took 3 Mississippi Social Security offices and an Inspector General office off ...

One of the vaccines for a specific strain of an avian virus could come from a research lab on the campus of South Dakota ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

President Donald Trump and Republicans are at a record high with voters as Democrats falter in the eyes of voters.

American take part in a poll about their views on different government programs and the funding that DOGE is currently ...

Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB)Phase 2 SHINE Data Show Dramatic Slowing of ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

The League of Women Voters forum for mayor, council and school board candidates touched on DEI issues, academics, public ...